Gabelli & Co Investment Advisers’s Enzymotec Ltd ENZY Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-191,550	Closed	-$2.27M	–	197
2017 Q4	$2.27M	Buy	+191,550	New	+$2.22M	0.3%	54

Gabelli & Co Investment Advisers's ENZY Position: Q1 2018 in Review

Gabelli & Co Investment Advisers sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 191,550 shares — an estimated $2.27M sold.

Gabelli & Co Investment Advisers first reported a position in ENZY in Q4 2017 and held it in 1 quarter. The position peaked at $2.27M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

Gabelli & Co Investment Advisers reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 191,550 Enzymotec Ltd shares in Q1 2018, an estimated $2.27M.
Gabelli & Co Investment Advisers first reported a position in Enzymotec Ltd in Q4 2017 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Enzymotec Ltd position peaked at $2.27M in Q4 2017.
0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2018, filed 9 May 2018.